Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial.

This study investigated the effect of Sinetrol-XPur on weight and body fat reduction in overweight or obese Korean participants. Among 100 overweight or obese participants enrolled in a 12-week randomized, double-blinded, controlled study, 86 participants completed the trial. Participants took either two Sinetrol-XPur tablets (450 mg per tablet) or two placebo tablets once a day. Bodyweight, body fat percentage, body mass index (BMI), body fat mass, waist circumference, and various safety parameters were measured. After the 12-week intervention, a significant reduction was observed in the body fat mass (P = .030) by dual-energy X-ray absorptiometry (DEXA), body weight (P = .002), and BMI (P = .002) compared to the placebo. Body fat percentage (P = .007) by DEXA showed a significant reduction in the Sinetrol-XPur group, but no difference compared to the control group. Abdominal metabolic risks by computed tomography and blood biochemistry analysis were significantly decreased in the Sinetrol-XPur group, but there were no differences between the Sinetrol-XPur and placebo groups. Safety profiles were not different between the two groups. These results suggested that Sinetrol-XPur significantly reduced body weight, body fat mass, and BMI in obese Korean subjects, which confirms the antiobesity effect of Sinetrol-XPur in the Korean population.

[1]  Xirong Guo,et al.  The clinical potential of circulating microRNAs in obesity , 2019, Nature Reviews Endocrinology.

[2]  A. Koutelidakis,et al.  Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences , 2019, Medicines.

[3]  P. Formisano,et al.  Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications , 2019, International journal of molecular sciences.

[4]  María del Mar Contreras,et al.  Phenolic compounds as natural and multifunctional anti-obesity agents: A review , 2019, Critical reviews in food science and nutrition.

[5]  W. So,et al.  Effects of FABP2 Ala54Thr gene polymorphism on obesity and metabolic syndrome in middle-aged Korean women with abdominal obesity. , 2019, Central European journal of public health.

[6]  P. Scherer,et al.  Adipogenesis and metabolic health , 2019, Nature Reviews Molecular Cell Biology.

[7]  N. Timpson,et al.  Associations of Body Mass and Fat Indexes With Cardiometabolic Traits , 2018, Journal of the American College of Cardiology.

[8]  Joel Dunning,et al.  Statistical primer: sample size and power calculations—why, when and how? , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  D. Meyre,et al.  Ethnic and population differences in the genetic predisposition to human obesity , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[10]  O. Kim,et al.  The Effects of Sinetrol-XPur on Lipolysis of Leptin-Deficient Obese Mice , 2017 .

[11]  Ji-Hye Jung,et al.  The Effect of Maté Extract on Body Weight and Fat Reduction in Obese Women: A Randomized Placebo-controlled Clinical Trial , 2016 .

[12]  M. Kiely,et al.  Guidance for the design and implementation of human dietary intervention studies for health claim submissions , 2016 .

[13]  J. Lakerveld,et al.  Lifestyle correlates of overweight in adults: a hierarchical approach (the SPOTLIGHT project) , 2016, International Journal of Behavioral Nutrition and Physical Activity.

[14]  P. Scherer,et al.  Targeting adipose tissue in the treatment of obesity-associated diabetes , 2016, Nature Reviews Drug Discovery.

[15]  유재명,et al.  Leptin 유전자 결핍 동물모델을 이용한 시네트롤(Sinetrol-XPur)의 항비만 효과와 cAMP를 통한 UCP-2 활성화 기전 연구 , 2016 .

[16]  S. Blair,et al.  Body Mass Index, the Most Widely Used But Also Widely Criticized Index: Would a Criterion Standard Measure of Total Body Fat Be a Better Predictor of Cardiovascular Disease Mortality? , 2016, Mayo Clinic proceedings.

[17]  C. Romain,et al.  A 12-week randomized double-blind parallel pilot trial of Sinetrol XPur on body weight, abdominal fat, waist circumference, and muscle metabolism in overweight men , 2015, International journal of food sciences and nutrition.

[18]  T. Laitinen,et al.  Assessment of body composition by dual‐energy X‐ray absorptiometry, bioimpedance analysis and anthropometrics in children: the Physical Activity and Nutrition in Children study , 2015, Clinical physiology and functional imaging.

[19]  Rostislav Chudnovskiy,et al.  Consumption of Clarified Grapefruit Juice Ameliorates High-Fat Diet Induced Insulin Resistance and Weight Gain in Mice , 2014, PloS one.

[20]  C. Dallas,et al.  Clinical Study to Assess the Efficacy and Safety of a Citrus Polyphenolic Extract of Red Orange, Grapefruit, and Orange (Sinetrol‐XPur) on Weight Management and Metabolic Parameters in Healthy Overweight Individuals , 2014, Phytotherapy research : PTR.

[21]  Sonia S Anand,et al.  Race/Ethnicity, Obesity, and Related Cardio-Metabolic Risk Factors: A Life-Course Perspective , 2013, Current Cardiovascular Risk Reports.

[22]  E. Sendra,et al.  Food Ingredients as Anti-Obesity Agents: A Review , 2013, Critical reviews in food science and nutrition.

[23]  Ambady Ramachandran,et al.  Obesity in Asia – is it different from rest of the world , 2012, Diabetes/metabolism research and reviews.

[24]  S. Going,et al.  The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults. , 2012, Metabolism: clinical and experimental.

[25]  Kee-Hong Kim,et al.  Food components with anti-obesity effect. , 2011, Annual review of food science and technology.

[26]  M. Dietrich,et al.  Effects of grapefruit, grapefruit juice and water preloads on energy balance, weight loss, body composition, and cardiometabolic risk in free-living obese adults , 2011, Nutrition & metabolism.

[27]  C. Tonelli,et al.  Blood orange juice inhibits fat accumulation in mice , 2010, International Journal of Obesity.

[28]  F. Bernard,et al.  Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[29]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[30]  F. Greenway,et al.  The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. , 2006, Journal of medicinal food.

[31]  K. Kondo,et al.  Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. , 2003, Journal of atherosclerosis and thrombosis.

[32]  Marc Montminy,et al.  Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.

[33]  Chwan-Li Shen,et al.  Novel insights of dietary polyphenols and obesity. , 2014, The Journal of nutritional biochemistry.

[34]  J. Hebebrand,et al.  Environmental and genetic risk factors in obesity. , 2009, Child and adolescent psychiatric clinics of North America.